Member Info for thomascromwell

A beard could be a disguise for a imposter stating an acquisition by year end.

Bazza,

By Easter the news from Croda will be in and my bet the cosmetic giants will be launching their formulations of the lysate to market as soon as they can. I share some negative doubts regarding SBTX, but have none regarding Croda or the company's future. Happy Xmas to all.

Ashman and the BoD's have taken huge salaries from the company which has impacted on the S/P, their collective corporate naivity has further undermined confidence as SOH and TW have alluded to. Acquisitions when Ashman has torpedoed the market cap.

Among Stuart Ashman's directorships, whilst at Turkington Bakeries he introduced deep-fried confectionary to the American market.

Closing in on germloids !

So SOH is employing a miniscule twit to give homecare too.

Well. 30 years at Croda ' this makes Ashman and his crony wet behind the ears.

We could do with this new appointee over at Sbtx. Are you listening Dr O'Hara.

Hmmmm...... This new appointee at Opti would also a make a valuable addition to the Sbtx board.

Elric, thanks for your reply, it is disappointing to see the placing proceeds disappear in administration costs. Take it easy and no concerts over the weekend.

Croda, must be looking on at this fiasco, how boardroom greed is reducing a viable partner. Return Professor O'Neill and SOH to the table.

It is perfectly reasonable to question the 1 million cost of the BoD's in achieving revenue of 130k. This is unacceptable.

Nick, BSFA as a company are surviving on vapours. This new direction into cosmetics is purely spin.

I think that may have just happened, Clio !

Having reviewed the El Greco podcasts, I belatedly conclude that Mr Ashman

has been subjected to unwarranted personal attacks. A podcast between TW and Ashman may clear further uncertainty and misconceptions;

Prior to the placing the S/P was 29 pence, forward selling reduced this with the CEO excitedly announcing his M&A agenda . I anticipate further company making news well before Christmas.

The Croda launch is just months away, which may change the cosmetic industry, this in itself will propel the market cap and any M&A if needed will be less dilutive. Logic is required and twaddle is not gentlemen.

SOH, today made his reasons for reducing OPTI's shareholding in SBTX to TW. and he say's.....

"I would prefer Skinbiotherapeutics to focus on growing revenues and making their company profitable and proving they can run a business before embarking on M&A activity which distracts the management, adds debt and dilutes shareholders."

I must say I agree.

Toyin,

Excellent summation.

I hope the overhang is gone !